|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02160 CARDIOFLOW-B
Nominal 
0.730 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 223,138 | 26.465% | 336,215 | 251,026 | 200,813 | 103,934 |
| Cost of Sales | (64,914) | 8.517% | (106,284) | (88,896) | (82,112) | (58,554) |
| Gross Profit | 158,224 | 35.671% | 229,931 | 162,130 | 118,701 | 45,380 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 2,448 | -- | (131,508) | (84,708) | 23,419 | (64,743) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (23,562) | -37.962% | (64,457) | (69,309) | (3,512) | 716 | |
| Profit / (Loss) before Taxation | (54,063) | -69.217% | (463,582) | (451,299) | (182,651) | (398,087) | |
| Taxation | (3,690) | -2.200% | (7,952) | (3,096) | (613) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,292 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (56,461) | -68.528% | (471,534) | (454,395) | (183,264) | (398,087) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (37,359) | -6.740% | (82,397) | (33,231) | (4,810) | 141,083 |
| Depreciation & Amortisation | 43,484 | 22.180% | 73,618 | 78,215 | 44,423 | 24,503 |
| Directors' Emoluments | -- | -- | 14,124 | 9,296 | 10,527 | 18,267 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -2.000 | -75.000% | -20.000 | -19.000 | -8.000 | -23.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.088) | (0.077) | (0.069) | (0.064) |
| NBV per share ($) | 0.896 | -- | 0.968 | 1.143 | 1.288 | -- |
| Remarks: | Real time quote last updated: 11/11/2024 08:17 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -56,461,000 |
| %Change | -68.528% |
| EPS / (LPS) | RMB -0.020 |
| NBV Per Share (¥) | RMB 0.896 |